Rankings
▼
Calendar
DNLI Q2 2025 Earnings — Denali Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
DNLI
Denali Therapeutics Inc.
$3B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$135M
Net Income
-$124M
EPS (Diluted)
$-0.72
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$80M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$139M
Stockholders' Equity
$1.0B
Cash & Equivalents
$141M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$135M
-$117M
-15.8%
Net Income
-$124M
-$99M
-25.3%
← FY 2025
All Quarters
Q3 2025 →